Massive study to reveal hidden costs of Alzheimer's in china

NCT ID NCT05995418

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large nationwide study in China will track nearly 10,000 people with Alzheimer's disease to measure the financial and emotional burden on patients and their caregivers. Researchers will collect data on medical expenses, care costs, and lost income. The goal is to fill gaps in understanding how Alzheimer's affects families and society in China, which could guide future support and policy decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could provide crucial data on the real-world costs and care needs of Alzheimer's in China, helping shape health policies and support services.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly lead to new therapies. Results may vary by region and may not fully capture all patient experiences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Xuanwu Hospital, Capital Medical University

    RECRUITING

    Beijing, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.